Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell
• ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Analyst Ratings for Vericel
Within the last quarter, Vericel (NASDAQ:VCEL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $37 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vericel (NASDAQ:VCEL) with a Buy and maintains $37 price target.
What’s Going On With Vericel Shares Trading Higher
Vericel Corp (NASDAQ: VCEL) shares are trading higher by 13.63% to $27.10 Tuesday after the company reported preliminary FY22 revenue results.
What Else?
FDA Approves MediWound’s NexoBrid For Burn Treatment
The FDA has approved MediWound Ltd’s (NASDAQ:MDWD) NexoBrid (anacaulase-bcdb) to remove eschar in adults with deep partial-thickness and/or full-thickness thermal burns.…
Biogen’s 2nd Alzheimer’s Antibody, BeiGene’s Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
FDA Accepts MediWound’s Refiling For Severe Thermal Burns Therapy For Review
The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.